COX-2 inhibitors block chemotherapeutic agent-induced apoptosis prior to commitment in hematopoietic cancer cells.

作者: Claudia Cerella , Cyril Sobolewski , Sébastien Chateauvieux , Estelle Henry , Michael Schnekenburger

DOI: 10.1016/J.BCP.2011.06.028

关键词:

摘要: Enzymatic inhibitors of pro-inflammatory cyclooxygenase-2 (COX-2) possess multiple anti-cancer effects, including chemosensitization. These effects are not always linked to the inhibition COX-2 enzyme. Here we analyze three enzyme (nimesulide, NS-398 and celecoxib) on apoptosis in different hematopoietic cancer models. Surprisingly, strongly prevent induced by a panel chemotherapeutic agents. We selected U937 cells as model sensitive for further studies. Here, provide evidence that protective effect is COX-independent. No suppression low basal prostaglandin (PG)E(2) production may be observed upon treatment inhibitors. Besides, non-active celecoxib analog 2,5-dimethyl-celecoxib able protect from well. demonstrate early prevention stress-induced apoptotic signaling, prior Bax/Bak activation. This preventive fits with an impairment ability agents trigger apoptogenic stress. Accordingly, etoposide-induced DNA damage attenuated presence In contrast, do exert any anti-apoptotic activity when challenged physiological stimuli (anti-Fas, TNFα or Trail) hydrogen peroxide, which require internalization and/or targeted chemoresistance proteins. Altogether, our findings show differential off-target intrinsic vs. extrinsic at very steps intracellular commitment. The results imply exacerbation phenomena implicated.

参考文章(49)
Kenneth K. Wu, Jun-Yang Liou, Cyclooxygenase Inhibitors Induce Colon Cancer Cell Apoptosis Via PPARδ → 14-3-3ε Pathway Methods in Molecular Biology™. ,vol. 512, pp. 295- 307 ,(2009) , 10.1007/978-1-60327-530-9_16
Xiao-Ming Yin, Kun Wang, Atan Gross, Yongge Zhao, Sandra Zinkel, Barbara Klocke, Kevin A. Roth, Stanley J. Korsmeyer, Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis Nature. ,vol. 400, pp. 886- 891 ,(1999) , 10.1038/23730
David C. Henshall, Tomohiro Araki, Clara K. Schindler, Jing-Quan Lan, Kenneth L. Tiekoter, Waro Taki, Roger P. Simon, Activation of Bcl-2-Associated Death Protein and Counter-Response of Akt within Cell Populations during Seizure-Induced Neuronal Death The Journal of Neuroscience. ,vol. 22, pp. 8458- 8465 ,(2002) , 10.1523/JNEUROSCI.22-19-08458.2002
Gary D Kruh, Martin G Belinsky, The MRP family of drug efflux pumps. Oncogene. ,vol. 22, pp. 7537- 7552 ,(2003) , 10.1038/SJ.ONC.1206953
N J Waterhouse, J A Trapani, A new quantitative assay for cytochrome c release in apoptotic cells. Cell Death & Differentiation. ,vol. 10, pp. 853- 855 ,(2003) , 10.1038/SJ.CDD.4401263
Q He, X Luo, W Jin, Y Huang, M V R Reddy, E P Reddy, M S Sheikh, Celecoxib and a novel COX-2 inhibitor ON09310 upregulate death receptor 5 expression via GADD153/CHOP. Oncogene. ,vol. 27, pp. 2656- 2660 ,(2008) , 10.1038/SJ.ONC.1210894
Sara L. O’Kane, Gina L. Eagle, John Greenman, Michael J. Lind, Lynn Cawkwell, COX-2 specific inhibitors enhance the cytotoxic effects of pemetrexed in mesothelioma cell lines Lung Cancer. ,vol. 67, pp. 160- 165 ,(2010) , 10.1016/J.LUNGCAN.2009.04.008
Malcolm Webb, Cary L. Raphael, Heinke Asbahr, Wendy N. Erber, Brian F. Meyer, The detection of rhodamine 123 efflux at low levels of drug resistance British Journal of Haematology. ,vol. 93, pp. 650- 655 ,(1996) , 10.1046/J.1365-2141.1996.D01-1680.X
B. Agarwal, P. Swaroop, P. Protiva, S. V. Raj, H. Shirin, P. R. Holt, Cox-2 is needed but not sufficient for apoptosis induced by Cox-2 selective inhibitors in colon cancer cells. Apoptosis. ,vol. 8, pp. 649- 654 ,(2003) , 10.1023/A:1026199929747